RecruitingNot ApplicableNCT07517627

Optimal Timings of Laparoscopic Cholecystectomy After ERCP in Patients With Gallstones Along With CBD Stones

Comparative Analysis of Early Versus Delayed Laparoscopic Cholecystectomy After Endoscopic Retrograde Cholangiopancreatography (ERCP) in Patients of Cholelithiasis With Choledocholithiasis


Sponsor

Rija Zainab

Enrollment

40 participants

Start Date

May 5, 2025

Study Type

INTERVENTIONAL

Conditions

Summary

This randomized controlled trial aims to compare the mean operative time and outcomes of early versus delayed laparoscopic cholecystectomy after ERCP in patients with cholelithiasis and choledocholithiasis. Patients will be randomized into two groups: early cholecystectomy (within 72 hours of ERCP) and delayed cholecystectomy (≥1 month after ERCP). Outcomes include operative time, intra-operative blood loss, hospital stay, and conversion to open cholecystectomy


Eligibility

Min Age: 14 YearsMax Age: 70 Years

Inclusion Criteria5

  • Patients diagnosed with cholelithiasis with choledocholithiasis based on clinical and radiological findings (right subcostal pain, presence of gallstones, and dilated common bile duct on ultrasound and MRCP)
  • Age 14 to 70 years
  • Both males and females
  • Duration of symptoms less than 3 days
  • Presence of common bile duct stone with successful clearance on ERCP

Exclusion Criteria2

  • Features suggestive of malignancy on imaging
  • Patients who develop severe pancreatitis after ERCP

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

PROCEDUREEarly laparoscopic cholecystectomy

Laparoscopic removal of gall bladder within 72hours of laparoscopic cholecystectomy

PROCEDUREDelayed Laparoscopic cholecystectomy

Laparoscopic removal of gall bladder 2 weeks or more after successful ERCP


Locations(1)

Shaikh Zayed hospital Lahore

Lahore, Punjab Province, Pakistan

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07517627


Related Trials